Brian Davis | CFO |
Matthew Pauls | President, CEO & Director |
Fredric Cohen | Chief Medical Officer |
Lindsay Rocco | Elixir Health Public Relations |
Hartaj Singh | Oppenheimer & Co. |
Jonathan Wolleben | JMP Securities LLC |
Welcome to the Strongbridge Biopharma's Third Quarter 2017 Earnings Conference Call. [Operator Instructions].
As a reminder, this conference call is being recorded. I would now like to turn the conference over to Lindsay Rocco, Elixir Health Public Relations. Ma'am, you may begin.